APA (7th ed.) Citation

R, B., B, T., L, R., W, K., A, S., M, v. d. W., & J, P. (2019). Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: Follow-up of the SWORD randomized controlled trial. BMC cancer, 19(1), 462. https://doi.org/10.1186/s12885-019-5615-3

Chicago Style (17th ed.) Citation

R, Burm, Thewes B, Rodwell L, Kievit W, Speckens A, van de Wal M, and Prins J. "Long-term Efficacy and Cost-effectiveness of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate and Colorectal Cancer Survivors: Follow-up of the SWORD Randomized Controlled Trial." BMC Cancer 19, no. 1 (2019): 462. https://doi.org/10.1186/s12885-019-5615-3.

MLA (9th ed.) Citation

R, Burm, et al. "Long-term Efficacy and Cost-effectiveness of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate and Colorectal Cancer Survivors: Follow-up of the SWORD Randomized Controlled Trial." BMC Cancer, vol. 19, no. 1, 2019, p. 462, https://doi.org/10.1186/s12885-019-5615-3.